1. April 8, 2020

    Coronavirus: Belgian directive for the reuse of surgical masks and FFP2/FFP3 masks in the context of the COVID-19 epidemic

    Heard from FAMHP

    A national guideline is available for the reprocessing of surgical masks and FFP2/FFP3 masks which allows reuse by cleaning, disinfecting or sterilising.

    Read more

  2. April 6, 2020

    Updated guidelines for the labelling and packaging of medicinal products for human use

    Heard from FAMHP

    Marketing authorisation holders of a medicinal product for human use are required to follow certain guidelines for the labelling and packaging of medicinal products. These guidelines have recently been updated.

    Read more

  3. April 6, 2020

    Coronavirus: details of the measures taken by the FAMHP to avoid shortages of medicines

    Heard from FAMHP

    Details van de maatregelen die het FAGG heeft genomen om tekorten aan geneesmiddelen te vermijden.

    Détail des mesures prises par l’AFMPS pour éviter les pénuries de médicaments.

    Read more

  4. April 6, 2020

    Coronavirus: hydroxychloroquine and chloroquine, beware of their elimination half-life and of the risk of drug interactions

    Heard from FAMHP

    Flash VIG-news: hydroxychloroquine en chloroquine, pas op voor hun eliminatie-halfwaardetijd en voor het risico op geneesmiddeleninteracties

    Flash VIG-news : hydroxychloroquine et chloroquine, attention à leur demi-vie d’élimination et aux risques d’interactions médicamenteuses

    Read more

  5. April 6, 2020

    Coronavirus: hydroxychloroquine, chloroquine and Kaletra (lopinavir + ritonavir) are distributed in a controlled way for a better follow-up of the treatment.

    Heard from FAMHP

    Coronavirus: hydroxychloroquine, chloroquine en Kaletra (lopinavir + ritonavir) worden voor een betere opvolging van de behandeling op een gecontroleerde manier verdeeld in België

    Coronavirus : hydroxychloroquine, chloroquine et Kaletra (lopinavir + ritonavir) sont distribués de manière contrôlée en Belgique, pour une surveillance accrue des traitements

    Read more

  6. April 6, 2020

    Coronavirus: measures taken by the FAMHP to avoid drug shortages

    Heard from FAMHP

    Coronavirus: maatregelen van het FAGG om geneesmiddelentekorten te vermijden

    Coronavirus : mesures de l’AFMPS pour éviter les pénuries de médicaments

    Read more

  7. April 6, 2020

    Coronavirus: guidelines for checking the compliance and suitability of certain surgical face masks

    Heard from FAMHP

    The FAMHP issues guidelines for checking the compliance and suitability of surgical face masks The guidelines are for companies not producing in accordance with European standards and for healthcare establishments and authorities ordering the masks.

    Read more

  8. April 6, 2020

    Nitrosamines in medicinal products: report results of risk assessments for impurities

    Heard from FAMHP

    Update 30.03.2020: the deadline for the first part of the risk assessment has been prolonged from 26th March 2020 to the 1st of Octobre 2020.

    Read more

  9. March 26, 2020

    Coronavirus: FAMHP seizes postal parcels containing counterfeit and other illegal medicines against COVID-19

    Heard from FAMHP

    Coronavirus: FAGG neemt postpakketten met namaak en andere illegale geneesmiddelen tegen COVID-19 in beslag

    Coronavirus : l'AFMPS saisit des colis postaux contenant des médicaments contrefaits et d’autres médicaments illégaux contre le COVID-19

    Read more

  10. March 26, 2020

    Coronavirus: Belgian guideline for the management of clinical trials during the coronavirus pandemic

    Heard from FAMHP

    A national guideline is available to complement European guidelines for the management of clinical trials during the coronavirus pandemic.

    Read more